Evidence mapPaperPMID 42100162Full record

ReviewFrontiers in chemistry2026

Precision intervention based on infection site: strategies and advances of magnetic nanomaterials in bacterial therapy.

Guangxin Zhang, Peiyi Liang, Xiying Fu, Yicun Wang

Abstract readReview
In one paragraph

Review in Frontiers in chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Guangxin Zhang *Department of Thoracic Surgery, Second Hospital of Jilin University, Changchun, China.
Peiyi Liang *Department of Medical Research Center, Second Hospital of Jilin University, Changchun, China.
Xiying FuDepartment of Endocrinology, Second Hospital of Jilin University, Changchun, China.
Yicun WangDepartment of Medical Research Center, Second Hospital of Jilin University, Changchun, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacterial infections, especially those involving drug-resistant pathogens and biofilms, pose a severe global health threat. Conventional antibiotic therapies are limited by poor penetration, low specificity, and bacterial resistance mechanisms. Magnetic nanoparticles (MNPs) offer a promising alternative by combining magnetically guided targeting, magnetothermal/photothermal effects, multifunctional drug delivery, and imaging capabilities. Their antibacterial efficacy depends critically on the anatomical and pathological features of the infection site. For skin and superficial infections, near-infrared (NIR) light, particularly in the second biological window (NIR-II), enables synergistic photothermal/photodynamic/chemodynamic therapies. For deep soft tissue and bone infections, alternating magnetic fields (AMF) provide deep-penetrating magnetothermal activation or targeted enrichment, often combined with image-guided intervention. For cavity organ and implant-related infections, surface functionalization, local drug delivery, and endoscopic energy application allow precise interfacial intervention. This review systematically discusses MNP-based strategies tailored to different infection sites, integrating advances in material design, synergistic mechanisms, and preclinical progress. It also addresses challenges in multifunctional integration, biosafety, and clinical translation, and outlines future directions toward intelligent, theranostic, and synergistic antibacterial platforms.

Indexed as

bacterial infectionbiofilm disruptionmagnetic nanoparticlesmagnetothermal effectphotothermal effectstimuli-responsive nanomaterialstargeting

Identifiers

PMID42100162
PMCPMC13143852

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.